{"id":15577,"date":"2021-12-02T13:30:32","date_gmt":"2021-12-02T13:30:32","guid":{"rendered":"https:\/\/staging.rayner.com\/blog\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/"},"modified":"2024-11-11T15:15:04","modified_gmt":"2024-11-11T15:15:04","slug":"rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe","status":"publish","type":"post","link":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/","title":{"rendered":"Rayner acquires Omidria to expand surgical offering in USA and Europe"},"content":{"rendered":"<p style=\"text-align: left;\"><strong>DECEMBER 02, 2021<\/strong>\u00a0\u2013\u00a0Worthing, United Kingdom.\u00a0Rayner Surgical Group (\u2018Rayner\u2019) and Omeros Corporation (\u2018Omeros\u2019) are delighted to announce the transfer of Omeros\u2019 ophthalmology assets, including Omidria<sup>TM<\/sup>, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including<a href=\"https:\/\/rayner.com\/global\/en\/iol\/\"> intraocular lenses (IOLs)<\/a>, for cataract surgeons.<\/p>\n<p style=\"text-align: left;\">Omidria<sup>TM<\/sup> has excellent and substantial clinical data supporting the maintenance of mydriasis (a dilated pupil) during surgery, protection of the eye from cystoid macular oedema and the reduction of post-operative pain without the use of opioids.<\/p>\n<p style=\"text-align: left;\">Omidria<sup>TM<\/sup> was approved by the US FDA in 2015 and has since become a key product in surgeons\u2019 arsenals. It was also granted EMA approval for marketing in Europe, and Rayner is excited to bring Omidria<sup>TM<\/sup> to European ophthalmologists through its direct businesses across Europe.<\/p>\n<p style=\"text-align: left;\">Commenting on the transfer, <strong>Dr Vance Thompson<\/strong>, a leading US ophthalmologist and Omidria<sup>TM<\/sup> user said, \u201cWe appreciate the security and improved care delivered by Omidria<sup>TM<\/sup> and are excited to see this combine with the Rayner IOL portfolio to create an important new partner for US cataract surgeons.\u201d<\/p>\n<p style=\"text-align: left;\"><strong>Mr Allon Barsam<\/strong>, a prominent London based ophthalmologist remarked, \u201cWe work closely with Rayner on their advanced technology IOLs and I also worked on the original clinical studies of Omidria<sup>TM<\/sup>. It\u2019s great to see this product coming to Europe and is consistent with Rayner\u2019s vision to provide superior visual outcomes.\u201d<\/p>\n<p style=\"text-align: left;\">\u201c<a href=\"https:\/\/rayner.com\/global\/\">Rayner<\/a> has over 100 years of heritage in ophthalmology including designing and manufacturing the world\u2019s first IOL with Sir Harold Ridley in 1949. In recent years the company has expanded its manufacturing and commercial presence, now selling in over 80 countries across the world with a significant direct presence in Europe. Our strategic focus is on visual outcomes and patient safety through a range of surgical products and eye drops. The inclusion of Omidria<sup>TM<\/sup> into the portfolio makes perfect sense and I am particularly excited to see the Omidria<sup>TM<\/sup> commercial team join Rayner,\u201d said <strong>Tim Clover<\/strong>, <a href=\"https:\/\/rayner.com\/global\/about-us\/management-team\/\">Rayner\u2019s CEO<\/a>.<\/p>\n<p style=\"text-align: left;\">The transaction is expected to complete, subject to clearances, by 31 December 2021. Rayner was advised by Rothschild &amp; Co, Freshfields Bruckhaus Deringer, PWC, LEK Associates, Avalere Health and Emmetropes.<\/p>\n<p style=\"text-align: left;\">END<\/p>\n<p style=\"text-align: left;\"><strong>About Rayner\u00a0 <\/strong><\/p>\n<p style=\"text-align: left;\">Since the implantation of the first\u00a0Rayner\u00a0intraocular lens by Sir Harold Ridley 1949, Rayner has continuously pioneered intraocular lens (IOL) design with a goal to improve vision and restore sight\u00a0worldwide. Today, Rayner\u2019s mission remains to deliver innovative and clinically superior ophthalmic products that respond to the expectations of our global customers to improve the sight and quality of life of their patients.<\/p>\n<p style=\"text-align: left;\">Headquartered in Worthing, United Kingdom, Rayner markets its IOL, OVD, digital health and dry eye portfolio, worldwide in over 80 countries through a network of distributors and includes direct sales teams in the United Kingdom, USA, Germany, Austria, Switzerland, Italy, India, Spain and Portugal.<\/p>\n<p style=\"text-align: left;\">To support Rayner\u2019s international growth, CVC Capital Partners VIII acquired a majority interest in the company in June 2021. Established in 1981 and with international reach and experience in the healthcare sector, CVC is a world leader in private equity and credit with $125 billion of assets under management and $165 billion of funds committed.<\/p>\n<p style=\"text-align: left;\">For\u00a0further information and media enquiries, please contact Rayner:<span style=\"color: #339966;\">\u00a0<a style=\"color: #339966;\" href=\"mailto:marketingteam@rayner.com\">marketingteam@rayner.com<\/a><\/span><\/p>\n<p style=\"text-align: left;\">EC 2021-90 12\/21<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DECEMBER 02, 2021\u00a0\u2013\u00a0Worthing, United Kingdom.\u00a0Rayner Surgical Group (\u2018Rayner\u2019) and Omeros Corporation (\u2018Omeros\u2019) are delighted to announce the transfer of Omeros\u2019 ophthalmology assets, including OmidriaTM, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including intraocular lenses (IOLs), for cataract surgeons.<\/p>\n","protected":false},"author":6,"featured_media":15782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[942,946],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rayner Acquires Omidria IOLs | Rayner Global<\/title>\n<meta name=\"description\" content=\"Rayner acquires Omidria to expand its surgical offerings in the US and Europe, further enhancing cataract surgery solutions worldwide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rayner Acquires Omidria IOLs | Rayner Global\" \/>\n<meta property=\"og:description\" content=\"Rayner acquires Omidria to expand its surgical offerings in the US and Europe, further enhancing cataract surgery solutions worldwide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"Rayner : Brazil\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-02T13:30:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-11T15:15:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png\" \/>\n\t<meta property=\"og:image:width\" content=\"480\" \/>\n\t<meta property=\"og:image:height\" content=\"552\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"kevin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kevin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/\",\"url\":\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/\",\"name\":\"Rayner Acquires Omidria IOLs | Rayner Global\",\"isPartOf\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png\",\"datePublished\":\"2021-12-02T13:30:32+00:00\",\"dateModified\":\"2024-11-11T15:15:04+00:00\",\"author\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/e8c292782c2fa4364d3a3829546f7118\"},\"description\":\"Rayner acquires Omidria to expand its surgical offerings in the US and Europe, further enhancing cataract surgery solutions worldwide.\",\"breadcrumb\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#primaryimage\",\"url\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png\",\"contentUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png\",\"width\":480,\"height\":552},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/rayner.com\/br-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rayner acquires Omidria to expand surgical offering in USA and Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\",\"url\":\"https:\/\/rayner.com\/br-pt\/\",\"name\":\"Rayner : Brazil\",\"description\":\"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rayner.com\/br-pt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/e8c292782c2fa4364d3a3829546f7118\",\"name\":\"kevin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ae78b6bc633ebd51238ea3bb16f6968b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ae78b6bc633ebd51238ea3bb16f6968b?s=96&d=mm&r=g\",\"caption\":\"kevin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rayner Acquires Omidria IOLs | Rayner Global","description":"Rayner acquires Omidria to expand its surgical offerings in the US and Europe, further enhancing cataract surgery solutions worldwide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/","og_locale":"en_GB","og_type":"article","og_title":"Rayner Acquires Omidria IOLs | Rayner Global","og_description":"Rayner acquires Omidria to expand its surgical offerings in the US and Europe, further enhancing cataract surgery solutions worldwide.","og_url":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/","og_site_name":"Rayner : Brazil","article_published_time":"2021-12-02T13:30:32+00:00","article_modified_time":"2024-11-11T15:15:04+00:00","og_image":[{"width":480,"height":552,"url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png","type":"image\/png"}],"author":"kevin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"kevin","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/","url":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/","name":"Rayner Acquires Omidria IOLs | Rayner Global","isPartOf":{"@id":"https:\/\/rayner.com\/br-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#primaryimage"},"image":{"@id":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#primaryimage"},"thumbnailUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png","datePublished":"2021-12-02T13:30:32+00:00","dateModified":"2024-11-11T15:15:04+00:00","author":{"@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/e8c292782c2fa4364d3a3829546f7118"},"description":"Rayner acquires Omidria to expand its surgical offerings in the US and Europe, further enhancing cataract surgery solutions worldwide.","breadcrumb":{"@id":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#primaryimage","url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png","contentUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/12\/Omidria.png","width":480,"height":552},{"@type":"BreadcrumbList","@id":"https:\/\/rayner.com\/br-pt\/rayner-acquires-omidria-to-expand-surgical-offering-in-usa-and-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rayner.com\/br-pt\/"},{"@type":"ListItem","position":2,"name":"Rayner acquires Omidria to expand surgical offering in USA and Europe"}]},{"@type":"WebSite","@id":"https:\/\/rayner.com\/br-pt\/#website","url":"https:\/\/rayner.com\/br-pt\/","name":"Rayner : Brazil","description":"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rayner.com\/br-pt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/e8c292782c2fa4364d3a3829546f7118","name":"kevin","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ae78b6bc633ebd51238ea3bb16f6968b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ae78b6bc633ebd51238ea3bb16f6968b?s=96&d=mm&r=g","caption":"kevin"}}]}},"_links":{"self":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15577"}],"collection":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/comments?post=15577"}],"version-history":[{"count":3,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15577\/revisions"}],"predecessor-version":[{"id":24154,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15577\/revisions\/24154"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media\/15782"}],"wp:attachment":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media?parent=15577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/categories?post=15577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/tags?post=15577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}